Inhibikase Therapeutics shares owned by Kennondale Capital Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Kennondale Capital Management
from 13F filings
Historical chart of Kennondale Capital Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Kennondale Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Kennondale Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $1.1M | 566k | 2.03 |
More positions owned by Kennondale Capital Management
View all positions for Kennondale Capital Management